In January, the FDA approved Masimo SET-powered MightySat Medical Pulse Oximeter to be sold over-the-counter without prescription. In December 2023, Masmo received the FDA clearance for Stork for ...
Masimo (NASDAQ: MASI ... and Radius VSMâ„¢, portable devices like Rad-67®, fingertip pulse oximeters like MightySat® Rx, and devices available for use both in the hospital and at home, such ...
Shares of Masimo stock opened at $169.96 on Monday. The firm has a fifty day moving average of $172.78 and a two-hundred day moving average of $152.24. The company has a debt-to-equity ratio of 0. ...
Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025 at 11:35 a.m. Eastern time. A ...